Aerie Pharmaceuticals, Inc. EBITDA 2013-2022 | AERI

Aerie Pharmaceuticals, Inc. ebitda from 2013 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Aerie Pharmaceuticals, Inc. Annual EBITDA
(Millions of US $)
2021 $-9
2020 $-122
2019 $-169
2018 $-206
2017 $-144
2016 $-95
2015 $-74
2014 $-49
2013 $-19
2012 $-14
2011 $-14
Aerie Pharmaceuticals, Inc. Quarterly EBITDA
(Millions of US $)
2022-09-30 $-23
2022-06-30 $-15
2022-03-31 $-30
2021-12-31 $62
2021-09-30 $-23
2021-06-30 $-22
2021-03-31 $-25
2020-12-31 $-27
2020-09-30 $-25
2020-06-30 $-34
2020-03-31 $-36
2019-12-31 $-42
2019-09-30 $-40
2019-06-30 $-42
2019-03-31 $-45
2018-12-31 $-50
2018-09-30 $-60
2018-06-30 $-55
2018-03-31 $-40
2017-12-31 $-60
2017-09-30 $-32
2017-06-30 $-27
2017-03-31 $-25
2016-12-31 $-28
2016-09-30 $-23
2016-06-30 $-22
2016-03-31 $-22
2015-12-31 $-20
2015-09-30 $-17
2015-06-30 $-18
2015-03-31 $-19
2014-12-31 $-16
2014-09-30 $-13
2014-06-30 $-12
2014-03-31 $-9
2013-12-31 $-6
2013-09-30 $-4
2013-06-30 $-4
2013-03-31 $-4
2012-09-30 $-3